Clinical Trial Update: Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on Roxadustat for anemia in chronic kidney disease patients not on dialysis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: AstraZeneca | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2019-12-16